Follow
Bin Gao
Bin Gao
Chief, Laboratory of Liver Diseases, NIAAA, NIH
Verified email at mail.nih.gov - Homepage
Title
Cited by
Cited by
Year
Alcoholic liver disease: pathogenesis and new therapeutic targets
B Gao, R Bataller
Gastroenterology 141 (5), 1572-1585, 2011
20932011
AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice
YU Li, S Xu, MM Mihaylova, B Zheng, X Hou, B Jiang, O Park, Z Luo, ...
Cell metabolism 13 (4), 376-388, 2011
17202011
The global burden of liver disease: the major impact of China
FS Wang, JG Fan, Z Zhang, B Gao, HY Wang
Hepatology 60 (6), 2099-2108, 2014
14322014
Liver: an organ with predominant innate immunity
B Gao, WI Jeong, Z Tian
Hepatology 47 (2), 729-736, 2008
11282008
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
A Bertola, S Mathews, SH Ki, H Wang, B Gao
Nature Protocols 8 (3), 627-637, 2013
9512013
Alcoholic liver disease
HK Seitz, R Bataller, H Cortez-Pinto, B Gao, A Gual, C Lackner, ...
Nature reviews Disease primers 4 (1), 16, 2018
9362018
Interleukin 22 (IL‐22) plays a protective role in T cell‐mediated murine hepatitis: IL‐22 is a survival factor for hepatocytes via STAT3 activation
S Radaeva, R Sun, H Pan, F Hong, B Gao
Hepatology 39 (5), 1332-1342, 2004
7172004
Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in nkg2d-dependent and tumor necrosis factor–related apoptosis-inducing ligand–dependent manners
S Radaeva, R Sun, B Jaruga, VT Nguyen, Z Tian, B Gao
Gastroenterology 130 (2), 435-452, 2006
7162006
Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression
H Song, KK Mak, L Topol, K Yun, J Hu, L Garrett, Y Chen, O Park, ...
Proceedings of the National Academy of Sciences 107 (4), 1431-1436, 2010
6192010
Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis
HS Kim, C Xiao, RH Wang, T Lahusen, X Xu, A Vassilopoulos, ...
Cell metabolism 12 (3), 224-236, 2010
5252010
Interleukin‐22 treatment ameliorates alcoholic liver injury in a murine model of chronic‐binge ethanol feeding: role of signal transducer and activator of transcription 3
SH Ki, O Park, M Zheng, O Morales‐Ibanez, JK Kolls, R Bataller, B Gao
Hepatology 52 (4), 1291-1300, 2010
4842010
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
B Gao, S Radaeva, O Park
Journal of leukocyte biology 86 (3), 513-528, 2009
4622009
Interleukin‐22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
X Kong, D Feng, H Wang, F Hong, A Bertola, FS Wang, B Gao
Hepatology, 2012
4532012
Hepatocytes: a key cell type for innate immunity
Z Zhou, MJ Xu, B Gao
Cellular & molecular immunology 13 (3), 301-315, 2016
4482016
Global liver disease burdens and research trends: analysis from a Chinese perspective
J Xiao, F Wang, NK Wong, J He, R Zhang, R Sun, Y Xu, Y Liu, W Li, ...
Journal of hepatology 71 (1), 212-221, 2019
4232019
Functional CB1 cannabinoid receptors in human vascular endothelial cells
J LIU, B GAO, F MIRSHAHI, AJ SANYAL, AD KHANOLKAR, ...
Biochemical Journal 346 (3), 835-840, 2000
4072000
Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation
Z Tian, R Sun, H Wei, B Gao
Biochemical and biophysical research communications 298 (3), 297-302, 2002
3612002
Molecular mechanisms of alcoholic fatty liver
V Purohit, B Gao, BJ Song
Alcoholism: Clinical and Experimental Research 33 (2), 191-205, 2009
3542009
Cytokines, STATs and liver disease
B Gao
Cell Mol Immunol 2 (2), 92-100, 2005
3522005
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver
W Jeong, D Osei-Hyiaman, O Park, J Liu, S Bátkai, P Mukhopadhyay, ...
Cell metabolism 7 (3), 227-235, 2008
3502008
The system can't perform the operation now. Try again later.
Articles 1–20